Evidence map›Paper›PMID 42010631›Full record

ArticleEpigenetics & chromatin2026

Comparative validation of oxidative bisulfite sequencing (oxBS) and chemical-assisted pyridine borane sequencing (CAPS) protocols for locus-specific 5-hydroxymethylcytosine quantification.

Katharina Pühringer, Philipp Czarda, Sebastian Iluca, Benno Fehringer, Pece Sherovski, Angelica Ohindovschi, Andreas Hainfellner, Lukas Reissig, Wolfgang J Weninger, Margit Cichna-Markl

Abstract readComparative StudyValidation Study
In one paragraph

Article in Epigenetics & chromatin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katharina PühringerFaculty of Chemistry, Institute of Analytical Chemistry, University of Vienna, Vienna, Austria.
Philipp CzardaFaculty of Chemistry, Institute of Analytical Chemistry, University of Vienna, Vienna, Austria.
Sebastian IlucaFaculty of Chemistry, Institute of Analytical Chemistry, University of Vienna, Vienna, Austria.
Benno FehringerFaculty of Chemistry, Institute of Analytical Chemistry, University of Vienna, Vienna, Austria.
Pece SherovskiInstitute of Chemistry, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University in Skopje, Skopje, North Macedonia.
Angelica OhindovschiDepartment of Pharmacognosy and Pharmaceutical Botany, Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, Republic of Moldova.
Andreas HainfellnerDivision of Anatomy, Centre for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Lukas ReissigDivision of Anatomy, Centre for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Wolfgang J WeningerDivision of Anatomy, Centre for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Margit Cichna-MarklFaculty of Chemistry, Institute of Analytical Chemistry, University of Vienna, Vienna, Austria. margit.cichna@univie.ac.at.

Funding

CEEPUS RO-0010-17-2223
6 · The paper itself

Abstract

backgroundDNA methylation is a key regulator of tissue-specific gene expression, cell differentiation, and development. In mammals, DNA methylation predominantly occurs as 5-methylcytosine (5mC) at CpG dinucleotides. DNA methylation is a dynamic and reversible process. Increasing evidence indicates that 5-hydroxymethylcytosine (5hmC), an oxidation product of 5mC, plays important roles in chromatin organization and gene regulation. Aberrant 5hmC levels have been associated with various neurological disorders and cancer types. Despite its biological relevance, accurate quantification of 5hmC at single-CpG resolution remains challenging due to its low abundance and methodological limitations of existing detection approaches.

resultsHere, we systematically compared bisulfite-based, bisulfite-free, and hybrid DNA conversion strategies for 5hmC analysis at single-CpG resolution with respect to accuracy, repeatability, lowest detectable (LDL) and lowest quantifiable (LQL) 5hmC levels, and DNA recovery. Method performance was evaluated using a 97 nt fragment of an MGMT enhancer containing two CpG sites. Synthetic oligonucleotides carrying cytosine, 5mC, or 5hmC at variable positions revealed that chemical-assisted pyridine borane sequencing (CAPS), a bisulfite-free approach, yielded the most accurate 5hmC quantification. However, false-positive signals resulted in increased LDL and LQL values, limiting its applicability to samples with low 5hmC abundance. Bisulfite-based protocols generally showed higher sensitivity, with the LDL and LQL values depending on the total incubation time. An optimized oxidative bisulfite protocol with a total incubation time of 140 min achieved low LDL and LQL values while substantially reducing the incubation time compared to previously published conditions. Among the oxidants tested, K

conclusionOur results demonstrate that bisulfite-based and bisulfite-free approaches for 5hmC analysis at single-CpG resolution exhibit distinct analytical strengths and limitations. Method selection should therefore be based on the specific biological question, the expected abundance of 5hmC, and practical constraints, such as DNA input and sample integrity, rather than by accuracy or sensitivity alone. It should be noted that analytical validation was primarily performed using single-stranded oligonucleotides.

Indexed as

5-MethylcytosineSequence Analysis, DNASulfitesAnimalsCpG IslandsDNA MethylationHumansOxidation-ReductionPyridinesReproducibility of Results5-hydroxymethylcytosine5-Methylcytosinehydrogen sulfitepyridinePyridinesSulfites5-hydroxymethylcytosineBisulfite sequencing (BS)Chemical-assisted pyridine borane sequencing (CAPS)DNA methylationMethod validationOxidative bisulfite sequencing (oxBS)

Identifiers

PMID42010631
PMCPMC13352651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.